| Extracellular reactive oxygen species drive apoptosis-induced proliferation via Drosophila macrophages CE Fogarty, N Diwanji, JL Lindblad, M Tare, A Amcheslavsky, K Makhijani, ... Current Biology 26 (5), 575-584, 2016 | 181 | 2016 |
| An unexpected friend− ROS in apoptosis-induced compensatory proliferation: implications for regeneration and cancer N Diwanji, A Bergmann Seminars in Cell & Developmental Biology 80, 74-82, 2018 | 113 | 2018 |
| Basement membrane damage by ROS-and JNK-mediated Mmp2 activation drives macrophage recruitment to overgrown tissue N Diwanji, A Bergmann Nature communications 11 (1), 3631, 2020 | 41 | 2020 |
| The beneficial role of extracellular reactive oxygen species in apoptosis-induced compensatory proliferation N Diwanji, A Bergmann Fly 11 (1), 46-52, 2017 | 31 | 2017 |
| Two sides of the same coin–compensatory proliferation in regeneration and cancer N Diwanji, A Bergmann The Drosophila Model in Cancer, 65-85, 2019 | 22 | 2019 |
| Ral-Arf6 crosstalk regulates Ral dependent exocyst trafficking and anchorage independent growth signalling A Pawar, JA Meier, A Dasgupta, N Diwanji, N Deshpande, K Saxena, ... Cellular signalling 28 (9), 1225-1236, 2016 | 19 | 2016 |
| Preclinical & clinical activity of autologous mRNA engineered chimeric antigen receptor monocytes for targeted cancer immunotherapy Y Wang, M Gerber, M Gorgievski, J D'Alessandro, N Diwanji, R Vale, ... Cancer Research 84 (6_Supplement), 3612-3612, 2024 | | 2024 |
| In vivo programming of natural killer cells and T cells using mRNA delivered cytotoxic chimeric antigen receptors N Diwanji, D Getts, Y Wang Cancer Research 84 (6_Supplement), 1319-1319, 2024 | | 2024 |
| Chimeric Antigen Cytotoxic Receptors for In Vivo Engineering of Tumor-Targeting NK Cells N Diwanji, D Getts, Y Wang ImmunoHorizons 8 (1), 97-105, 2024 | | 2024 |
| Abstract CT131: Initial preclinical and clinical experience of autologous engineered monocytes in T cell lymphoma patients M Gerber, T Prod'homme, Y Wang, KR Kieffer-Kwon, N Diwanji, ... Cancer Research 83 (8_Supplement), CT131-CT131, 2023 | | 2023 |
| Chimeric Antigen Cytotoxic Receptors for In-Vivo Engineering of Tumor-targeting Natural Killer Cells N Diwanji, D Getts, Y Wang bioRxiv, 2023.11. 07.565144, 2023 | | 2023 |
| Abstract LB005: ATAK receptors, a new class of chimeric antigen receptors that harness innate immunity in myeloid cells to target cancer N Diwanji, KR Kieffer-Kwon, T Prod’homme, B McCreedy, Y Wang, ... Cancer Research 82 (12_Supplement), LB005-LB005, 2022 | | 2022 |
| 393 ATAK receptors, a new class of chimeric antigen receptor that harness innate immunity in myeloid cells to target cancer N Diwanji, E Cochran, M Gorgievski, T Prod’homme, Y Wang J Immunother 10 (2), A1-A1595, 2022 | | 2022 |
| ATAK™ receptors, harnessing innate immunity to program myeloid cells to kill cancer Y Wang, N Diwanji, T Nicholson, S Mukherjee, D Getts Cytotherapy 23 (5), S96, 2021 | | 2021 |
| Harnessing Myeloid Cells for Peripheral T-Cell Lymphoma Immunotherapy: The CD5 ATAK (TM) Myeloid Cell Platform KR Kieffer-Kwon, Y Wang, C Rane, X Du, P Tavares, N Diwanji, N Bisaria, ... MOLECULAR THERAPY 29 (4), 326-326, 2021 | | 2021 |
| The HER2-ATAK (TM) Myeloid Cells as a Therapeutic Modality for Solid Tumors Y Wang, C Rane, P Tavares, KR Kieffer-Kwon, ZL Ling, N Bisaria, ... MOLECULAR THERAPY 29 (4), 325-325, 2021 | | 2021 |
| Role of Tissue Microenvironment in Recruiting Macrophages During Apoptosis-induced Proliferation N Diwanji | | 2020 |
| Ral-Arf6 crosstalk regulates Ral dependent exocyst trafficking and anchorage independent growth signalling JA Meier, N DIWANJI, N BUWA, K SAXENA, A DASGUPTA, ... Elsevier BV, 2016 | | 2016 |
